13F Pro

SEC Form 4 reporting owner

Sun Nelson

Sun Nelson has filed 4 Form 4 transactions reported between December 11, 2025 and September 11, 2026, as Chief Financial Officer of Aardvark Therapeutics, Inc..

Name as filed: Sun Nelson

Open-market buys, 24 mo
$43K
1 lines
Open-market sales, 24 mo
$395K
2 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 11, 2026
transaction date

Roles and reported holdings

  • AARDAardvark Therapeutics, Inc.
    Dec 11, 2025 – Sep 11, 2026

    Chief Financial Officer

    Held directly35,475 sh as of Sep 11, 2026 · Form 4

    24 months: $43K bought · $395K sold

Transaction history

All 4 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 11, 2026AARDOpen-market saleCode S · direct62,000$321K@ $5.18Form 4
Sep 10, 2026AARDOpen-market saleCode S · direct14,754$74K@ $5.00Form 4
Feb 9, 2026AARDChief Financial OfficerGrant or awardCode A · direct70,549—Form 4
Dec 11, 2025AARDChief Financial OfficerOpen-market purchaseCode P · direct3,000$43K@ $14.40Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.